Literature DB >> 11208114

Intracellular surveillance: controlling the assembly of MHC class I-peptide complexes.

P Cresswell1.   

Abstract

MHC class I molecules bind with high affinity to peptides in the endoplasmic reticulum and display them on the cell surface. Here they are screened by CD8-positive T-lymphocytes for the presence of foreign, pathogen-derived peptides within the mass of self-peptides expressed. MHC class I assembly is a complicated process involving a number of accessory molecules, including specialized components as well as common chaperones. Our understanding of the mechanisms involved, while quite advanced, is far from complete.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11208114     DOI: 10.1034/j.1600-0854.2000.010402.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  16 in total

1.  Purification of correctly oxidized MHC class I heavy-chain molecules under denaturing conditions: a novel strategy exploiting disulfide assisted protein folding.

Authors:  Henrik Ferré; Emmanuel Ruffet; Thomas Blicher; Christina Sylvester-Hvid; Lise Lotte B Nielsen; Timothy J Hobley; Owen R T Thomas; Søren Buus
Journal:  Protein Sci       Date:  2003-03       Impact factor: 6.725

2.  Direct peptide-regulatable interactions between MHC class I molecules and tapasin.

Authors:  Syed Monem Rizvi; Malini Raghavan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

3.  Requirements for the selective degradation of endoplasmic reticulum-resident major histocompatibility complex class I proteins by the viral immune evasion molecule mK3.

Authors:  Xiaoli Wang; Rose Connors; Michael R Harris; Ted H Hansen; Lonnie Lybarger
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 4.  Pathways for antigen cross presentation.

Authors:  Pierre Guermonprez; Sebastian Amigorena
Journal:  Springer Semin Immunopathol       Date:  2004-12-03

5.  Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing.

Authors:  Danijela Koppers-Lalic; Eric A J Reits; Maaike E Ressing; Andrea D Lipinska; Rupert Abele; Joachim Koch; Marisa Marcondes Rezende; Pieter Admiraal; Daphne van Leeuwen; Krystyna Bienkowska-Szewczyk; Thomas C Mettenleiter; Frans A M Rijsewijk; Robert Tampé; Jacques Neefjes; Emmanuel J H J Wiertz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-25       Impact factor: 11.205

6.  Bovine herpesvirus 1 UL49.5 protein inhibits the transporter associated with antigen processing despite complex formation with glycoprotein M.

Authors:  Andrea D Lipińska; Danijela Koppers-Lalic; Michał Rychłowski; Pieter Admiraal; Frans A M Rijsewijk; Krystyna Bieńkowska-Szewczyk; Emmanuel J H J Wiertz
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

7.  A tubular EHD1-containing compartment involved in the recycling of major histocompatibility complex class I molecules to the plasma membrane.

Authors:  Steve Caplan; Naava Naslavsky; Lisa M Hartnell; Robert Lodge; Roman S Polishchuk; Julie G Donaldson; Juan S Bonifacino
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

8.  Tapasin and ERp57 form a stable disulfide-linked dimer within the MHC class I peptide-loading complex.

Authors:  David R Peaper; Pamela A Wearsch; Peter Cresswell
Journal:  EMBO J       Date:  2005-09-29       Impact factor: 11.598

9.  Edmonston measles virus prevents increased cell surface expression of peptide-loaded major histocompatibility complex class II proteins in human peripheral monocytes.

Authors:  Mamadi Yilla; Carole Hickman; Marcia McGrew; Elizabeth Meade; William J Bellini
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Inhibition of cellular alpha-glucosidases results in increased presentation of hepatitis B virus glycoprotein-derived peptides by MHC class I.

Authors:  Ender Simsek; Gomathinayagam Sinnathamby; Timothy M Block; Yuanjie Liu; Ramila Philip; Anand S Mehta; Pamela A Norton
Journal:  Virology       Date:  2008-12-16       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.